Indians Are Worshiping Goddess Corona To Stop COVID-19 Pandemic
Harin - Jul 24, 2020
A group of women from a West Bengal village decided to fight COVID-19 by setting up a small shrine to worship Corona Mai aka Corona Goddess.
- This Man's Super-Antibody Can Be Diluted 10,000 Times But Still Works Against COVID-19
- These Indian Cities Are Under Lockdown Again In 2021
- India To Review Covishield Vaccine After Report Of Blood Clots Following Vaccination
India is one of the worst-hit countries by the COVID-19 pandemic. And now, people are turning to divine and spiritual powers, hoping they could be protected from the coronavirus.
Indian media recently reported that a group of women from a West Bengal village decided to fight back in their own way. The group set up a small shrine near the Chinnamasta pond to worship Corona Mai aka Corona Goddess. They started to bring offerings like vegetables, fruits, jaggery, and ghee, burning incense, singing mantras and songs. One of the women said that they would continue to pray and worship the goddess until the pandemic ended.
Worshippers of the Corona Goddess are women from early 20s to 70s. All of them believe that praying to the goddess is the best way to fight the pandemic.
A 56-year-old woman said that the group worshiped the Corona goddess every Monday and Friday.
In another case, a man from Kerala also set up a whole temple to pray to a “coronavirus goddess.” He wants to dedicate the temple to scientists, health workers, rescue officers, police fire, journalists, and other media personnel who are contributing their efforts to the fight against the pandemic.
Meanwhile, the Indian pharmaceutical industry is racing to produce COVID-19 vaccines. For a long time, India has become the world’s vaccine manufacturing hub.
Serum India will be in charge of manufacturing the COVID-19 vaccine currently on human trials at Oxford University, the UK. The company’s goal is to produce four to five million doses of vaccines each month in the first six months. After that, they might scale up the production to 10 million doses monthly. By September-October, Serum Institute is planning to produce 20 to 40 million doses. By doing this, the product will be available in other countries as well.
Meanwhile, COVAXIN, the first indigenous COVID-19 vaccine of India, developed by Bharat Biotech has received approval to carry out human clinical trials.
>>> Llama-Based 'Antibody Cocktail' Can Treat COVID-19 Patients In Severe Condition
Comments
Sort by Newest | Popular